It is common for sponsors to switch digital platforms between clinical trial phases, but sponsors can achieve much by using ...

Two years after the FDA placed partial clinical hold, Avidity can resume research of del-desiran as a treatment for myotonic ...

Recordati has reached an agreement with Sanofi for acquiring the worldwide rights to Enjaymo, the only approved treatment ...

Bristol Myers Squibb (BMS) has received approval from the US Food and Drug Administration (FDA) for Opdivo to treat adults ...

The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...

Teva Pharmaceuticals International and mAbxience have entered into a worldwide licencing agreement to develop an anti ...

National Resilience’s subsidiary Resilience Government Services has received around $17.5m in funding for expanding critical ...

Novo Nordisk’s chief scientific officer Marcus Schindler led the keynote address at ELRIG Drug Discovery 2024 in London, UK.

At ELRIG 2024, Dr. Maria Duca described how her lab’s rational design approach bypasses lengthy screening protocols.

Vevizye is used to treat moderate to severe DED in adults unresponsive to tear substitutes. Novaliq and Laboratoires Théa ...

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...

Resolution plans to use Series B investment to advance the development of its macrophage therapies in inflammatory and ...